Medical - Healthcare Plans · NYSE
当前价格
$408.52
PE Ratio (TTM)
30.9x
内在价值
$614.94
安全边际 +33.6%
截至 2026-06-12,对 UnitedHealth Group Incorporated(UNH)每股收益 $13.24 套用 31.0x 的盈利倍数,得出每股公允价值估算约 $614.94,当前股价为 $408.52。
基于盈利倍数的公允价值对所选倍数很敏感。在敏感性网格上,估算区间为 $518.53 至 $723.69。这是锚定盈利的相对估算,并非事实定论。如需基于现金流的视角,请参阅 DCF 页面的内在价值估算。
我们的 PE 模型如何运作 · 用 PE 模式重新计算 · UNH 内在价值(DCF 视角)
在 $408.52 的价格下,UNH 远低于其基于 PE 的公允价值估算。按此模型,相对其盈利能力该股看起来便宜,但在过度解读前请先核实盈利是否可持续。
竞争护城河
↑规模经济效应
作为最大的医疗保健计划提供商,UNH通过庞大的会员基础和供应商网络,获得了显著的成本议价能力。这使其能够提供更具竞争力的价格,并维持健康的利润率。
↑数据与技术优势
UNH积累了海量的医疗保健数据,并利用先进技术进行分析,以优化医疗服务、预测趋势和管理风险。这种数据驱动的洞察力是竞争对手难以复制的。
↑多元化业务布局
除了医疗保险,UNH还通过Optum提供药品福利管理、技术服务和医疗服务。这种多元化降低了对单一业务的依赖,并创造了协同效应。
投资风险
↓监管政策变化
医疗保健行业受到严格监管,政府政策的任何重大调整,如医疗补助和医疗保险的改革,都可能对UNH的盈利能力和业务模式产生深远影响。
↓医疗成本上升
尽管近期有成本趋缓的迹象,但长期来看,医疗服务和药品成本的持续上涨会给保险公司的利润率带来压力,并可能导致保费上涨。
↓竞争加剧
尽管UNH规模庞大,但医疗保健计划市场竞争激烈,包括其他大型保险公司和新兴的医疗技术公司。持续的创新和成本控制是保持领先的关键。
基准情形
内在价值
$614.94
安全边际
+33.6%
预期年化收益
+8.5%
基准情形假设:盈利年增长率 16.1%、目标 P/E 倍数 31x、折现率 10%、预测 5 年。数据截至 2026-06-12。
本基准情形采用默认假设,不构成投资建议。当目标 PE 或盈利增长率变化时,公允价值会显著改变。打开计算器可设置你自己的假设,并查看完整的敏感性区间。
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
PE Ratio (TTM)
30.9x
PEG Ratio
n/m
Earnings Yield
3.24%
ROE (TTM)
12.4%
Revenue/Share (TTM)
$494.19
Dividend Yield
2.19%
Debt/Equity
0.75x
UNH 的过去 12 个月市盈率反映投资者为 UnitedHealth Group Incorporated 每一美元收益所支付的价格。该指标在与Medical - Healthcare Plans同类公司和公司自身历史区间对比时最有意义。
UNH 的市盈率 30.9x 结合 PEG 比率 -0.69 提供了增长调整后的视角。UNH 盈利为负,市盈率和 PEG 比率此时均无意义,无法判断股票被高估还是低估。注意 PE 估值最适合盈利稳定的成熟公司——对于高增长或周期性Medical - Healthcare Plans,DCF 分析可能更合适。
对 UnitedHealth Group Incorporated 使用 PE 估值的步骤:(1) 将当前市盈率 (30.9x)与Medical - Healthcare Plans中位数对比评估相对定价,(2) 查看 PEG 比率 (-0.69)以调整增长预期,(3) 参考 5 年 PE 历史区间判断当前位置,(4) 用目标 PE 乘以前瞻 EPS 估算公允价值。这种相对估值方法与 DCF 的绝对估值互为补充。
UNH 的 PEG 比率为 -0.69,由市盈率(30.9x)除以预期盈利增速计算。由于 UNH 盈利为负,其 PEG 比率没有意义,不应被解读为低估或高估的信号。注意 PEG 的准确性取决于增长预期的可靠性。
PE 市盈率给出快速的相对定价——UNH 相对于Medical - Healthcare Plans同类的估值水平。DCF 基于预期自由现金流提供绝对价值。建议用 PE 做快速筛选,用 DCF 做深度分析。两种方法各有盲区:PE 忽略了资本结构和现金流质量,DCF 则对增长率和折现率假设非常敏感。
PE 与 DCF 使用不同的方法和假设为 UNH 估值,因此两者的结论可能不同。可对比 DCF 内在价值。
价格截至 2026-06-12。 财务数据来自 Financial Modeling Prep(过去 12 个月)· 估值方法论由 Charlie Wang 提供。
这是估计值,不构成投资建议。